Hepatitis D virus (HDV) is the only known human satellite virus, and it requires hepatitis B virus 3 (HBV) to form infectious particles. Until 2018 HDV was the sole representative of the 4 genus Deltavirus. The subsequent identification of HDV-like agents in non-human hosts indicated a 5 much longer evolutionary history of deltaviruses than previously hypothesized. Interestingly, none 6 of the HDV-like agents were found in co-infection with an HBV-like agent suggesting that these 7 viruses use different helper virus(es). Here we show, using snake deltavirus (SDeV), that HBV 8
INTRODUCTION 1 7
Viroids found in higher plants are the smallest known infectious agents comprised of only 1 8 circular RNA 1 . After the discovery of viroids in 1971 2 , hepatitis D virus (HDV) was described in 7 SDeV genome, and subcloned the insert in genomic (pCAGGS-SDeV-FWD) and antigenomic 9 8 (pCAGGS-SDeV-REV) orientation into the mammalian expression vector pCAGGS/MCS. The 9 9 expression constructs are schematically presented in Figure 2 . We then used the generated 1 0 0 constructs to transfect B. constrictor (I/1Ki) and African green monkey (Vero E6) kidney cells. IF 1 0 1 staining of the transfected cells at 1, 2, 3, and 4 days post transfection demonstrates that SDAg can 1 0 2 be detected from day 1 onwards ( Figure 3A) . The result further indicates that SDAg is expressed in however, SDAg was mostly detected in the cytoplasm for both constructs. We also analyzed the 1 1 0 transfected cells by western blotting (WB) and could demonstrate an increasing amount of SDAg 1 1 1 during the four days of transfection ( Figure 3B ). After demonstrating that replication of SDeV can be initiated in both boid and monkey kidney cells 1 1 4 by transfecting the pCAGGS-SDeV-FWD plasmid, we wanted to test if SDeV replication would 1 1 5 also occur in human cell lines. We transfected human lung carcinoma (A549), hepatocyte ( Figure 4A ). In addition, SDAg was also strongly expressed in the nucleus of A549 and Hep G2 1 2 0 cells. To study whether similar differences in the SDAg localization would occur also in snake Encouraged by these findings, we tried the same approach for mammalian cells (Vero E6), but 1 4 1 based on IF screening this cell line was not able to maintain SDeV infection when cultured at 37 °C. To see if temperature is an influencing factor, we then kept the transfected Vero E6 cells at 30 °C, 1 4 3 but temperature had little or no effect on virus replication as judged by the number of cells As we had succeeded in isolating SDeV from the brain of a B. constrictor that showed no traces of a 1 4 8 control. At 2-5 dpi we IF-stained the cells for SDAg and counted the number of fluorescent foci at 1 7 0 each time point. The non-superinfected I/1Ki-Δ cells did not produce infectious particles, while 1 7 1 cells superinfected with either reptarenaviruses or hartmaniviruses produced infectious SDeV 1 7 2 particles ( Figure 6A ). The production of infectious SDeV particles appeared to be most efficient in 1 7 3 HISV-1 infected cells, while UHV-2 infected cells produced the lowest amount of infectious SDeV 1 7 4 particles ( Figure 6A ). The observed difference between the amounts of infectious SDeV particles 1 7 5 produced in UHV-2 vs. UGV-1 infected cells might be related to the comparatively lower 1 7 6 replication rate of UHV-2 reported in our previous study 29 . We then wanted to try purification of the SDeV particles and used ultracentrifugation to pellet the 1 7 8 particles secreted from mock, UHV-2, UGV-1, and HISV-1 infected I/1Ki-Δ cells; WB served to 1 7 9 detect SDAg in the obtained pellets. The results show that more SDAg could be pelleted from the 1 8 0 supernatants of reptarenavirus and hartmanivirus superinfected I/1Ki-Δ cells than from the mock-1 8 1 infected I/1Ki-Δ cells ( Figure 6B ). Interestingly, also the mock infected cells released particles 1 8 2 containing SDAg, however, these particles are non-infectious as described above ( Figure 6A ). We superinfecting reptarenavirus or hartmanivirus particles. Unfortunately, even with varying 1 8 5 centrifugation times (18 h and 4 h) we were unable to separate SDAg and reptarenaviruses or 1 8 6 hartmaniviruses into different fractions ( Figure 6C ). Because superinfection of I/1Ki-Δ cells with both reptarenaviruses and hartmaniviruses resulted in 1 9 0 production of infectious SDeV particles, we wanted to study which of the structural proteins are 1 9 1 required for particle production. While the envelope of both classical arenaviruses (genus 1 9 2 Mammarenavirus) and reptarenaviruses comprises both matrix protein (ZP) and spike complexes, 1 9 3 secreted from I/1Ki-Δ migrates to the same fractions as reptarenaviruses and hartmaniviruses in 2 7 5 density gradient ultracentrifugation. By superinfecting I/1Ki-Δ with reptarenaviruses and 2 7 6 hartmaniviruses we could induce production of infectious SDeV particles. We could further 2 7 7 demonstrate that the expression of glycoproteins alone induces formation of infectious SDeV 2 7 8 particles, even though the ZP of arenaviruses is known to contribute to budding of virions 44 . The co-2 7 9 transfection of ZPs did not improve the efficiency of SDeV particle production. Interestingly, 2 8 0 hartmanivirus infection or the expression of hartmanivirus glycoprotein seemed to induce the most 2 8 1 efficient production of infectious SDeV particles. The dissimilarity could be due to the suggested 2 8 2 differences between reptarenavirus (no cytoplasmic tail) and hartmanivirus (cytoplasmic tail with 2 8 3 putative late domains) glycoproteins 29 . We could further show that the expression of 2 8 4 mammarenavirus (LCMV or JUNV) and hantavirus (PUUV) glycoproteins also induces formation 2 8 5 of infectious SDeV particles. We have also applied the same approach for HDV and observed that 2 8 6 the expression of arenavirus and hantavirus glycoproteins is sufficient for infectious particle 2 8 7 production. Since parallel findings using hepacivirus, flavivirus and vesiculovirus helpers have been 2 8 8 recently published by Perez-Vargas and co-authors 27 , we have decided not to include our results 2 8 9 regarding HDV in this manuscript. Taken altogether, these findings imply that various deltaviruses 2 9 0 would rely on several different helper viruses to complete their life cycle. These newly described characteristics of deltaviruses raise numerous questions regarding the range 2 9 2 of possible helper viruses, and factors contributing to deltavirus-glycoprotein interactions and 2 9 3 subsequent infectious particle formation. Further studies will need to address which viruses can act 2 9 4 as deltavirus helpers. It is tempting to speculate that deltaviruses would be opportunistic microbes, 2 9 5 the exit (or infectious particle formation) of which would rely on persistent, latent, or recurring Additionally, recurring infections such as those caused by ortho-, paramyxo-or coronaviruses, or 3 0 1 latent infections caused by e.g. herpesviruses could contribute to the spread of deltaviruses. It seems 3 0 2 thus fair to speculate that HDV could present merely the tip of an iceberg in terms of human syndrome, it appears that deltaviruses could be the underlying cause or agents able to exacerbate 3 0 7 disease in both animals and humans. The common ancestor of deltaviruses could be found among 3 0 8 viroids of higher plants, since they show the highest similarities with HDV 4 . Since a deltavirus was 3 0 9 already identified in termites 28 , one could hypothesize that the deltavirus ancestor was transmitted 3 1 0
Superinfection of I/1Ki-Δ cells with reptarenaviruses and hartmaniviruses produces infectious

Transfection of I/1Ki-Δ cells with viral glycoproteins induces production of infectious
to Animalia from plants. Indeed, Bogaert and colleagues showed the presence of viroids in aphids 3 1 1 feeding on infected plants 48 which could support the above hypothesis. Deltaviruses are likely widespread both worldwide and across different taxa. So far novel 3 1 3 deltaviruses have been found in snakes, birds, fish, amphibians, and invertebrates 5,6,28 . These in the field of deltavirus research. We used the following established cell lines: human hepatocellular carcinoma, Hep G2 (American 3 2 1 type culture collection, ATCC); African green monkey kidney, Vero E6 (ATCC); human embryonic 3 2 2 kidney, HEK293FT (Thermo Fisher Scientific); human lung carcinoma, A549 (ATCC). Boa For maintaining the cultured mammalian and I/1Ki cell lines we used Minimal Essential Medium nM L-Alanyl L-glutamine, 100 μg/ml of streptomycin, and 100 U/ml of penicillin. We kept the 3 3 1 cells in incubators with 5% CO 2 and at 30 °C or 37 °C. To obtain cell lines persistently infected with SDeV, we passaged the cells (culturing conditions as 3 3 3 described above) transfected with plasmid bearing two copies of the SDeV genome (described 3 3 4 below) until we obtained a confluent 175-cm 2 flask and were able to prepare ampoules for storage. The following permanently infected cell lines were generated: I/1Ki-Δ, V/1Ki-Δ, V/1Liv-Δ, V/2Hz- For superinfection studies we used two reptarenaviruses: University of Helsinki virus-2 (UHV-2 29 ) 3 3 8
and University of Giessen virus-1 (UGV-1 33 ), and one hartmanivirus, Haartman Institute Snake virus-1 (HISV-1 29 ). We ordered a synthetic gene from Gene Universal bearing the snake deltavirus genome 3 4 2 (MH988742.1) in duplicate (starting from residue 216 and ending at 215 i.e. exactly two copies of EcoRV restriction sites at both ends. We followed the manufacturer's protocols throughout the 3 4 5 cloning. We used FastDigest EcoRV (ThermoFisher Scientific), agarose gel electrophoresis and the 3 4 6
GeneJET Gel extraction kit (ThermoFisher Scientific) to purify the synthetic insert. For subcloning (ThermoFisher Scientific) to blunt the 5´ and 3´ overhangs, and the GeneJET Gel extraction kit 3 5 0 (ThermoFisher Scientific) to purify the plasmid after agarose gel electrophoresis. We ligated the °C into 5 ml of 2xYT medium (16 g/l tryptone, 10 g/l yeast extract, 5 g/l NaCl), prepared minipreps For recombinant expression of HBV S-Ag, we ordered a synthetic gene (from GeneUniversal) and prepared plasmid stocks as described above. We also ordered codon-optimized (for human) 3 6 5 synthetic genes (from GeneUniversal) based on UGV-1 ZP (AKN10693.1), with 5´ EcoRI and 3´ 3 6 6
XhoI restriction sites, and cloned the gene to pCAGGS/MCS for expression as described above. For ThermoFisher Scientific) with the following primers:
GGAGGTACCCCGTATTTTTCAATGGGACA-3´ to generate inserts, purified the inserts using FastDigest EcoRI and SmaI (ThermoFisher Scientific) for UGV-1 GPC and FastDigest EcoRI and KpnI (ThermoFisher Scientific) for HISV-1 GPC, purified the inserts as described above, ligated linearized with the respective restriction enzymes, and prepared the plasmid stocks as described and Gc (residues 637-1148 of CCH22848.1) we used the following primers: PUUV-Gn-fwd 5´-
AAGAGAATTCATGTTCTTCGTGGGCCT-3´, PUUV-Gc-rev 5´- both pCAGGS-HA and pCAGGS-FLAG 52 and prepared plasmid stocks as described above. To generate affinity purified anti-UHV NP and anti-SDAg antibodies, we coupled baculovirus Fast Flow (GE Healthcare Life Sciences) following the manufacturer's protocol. We used a for long term storage. To determine optimal dilutions, we titrated the antibodies on clean and 4 0 7
infected I/1Ki-Δ cells (SDeV with and without reptarenavirus infection), the antibodies generated We performed SDS-PAGE (self-prepared gels and 4-20% Mini-PROTEAN® TGX gels from Bio-4 1 2
Rad) and immunoblotting using methods described in Korzyukov et al., 2016 54 . The antibody 4 1 3 dilutions used were 1:10,000 to 1:20,000 for the rabbit anti-SDAg pAb 6 , 1:4,000 for the mouse anti 4 1 4
HA-tag mAb (AE008, ABclonal), 1:10,000 for AlexaFluor 680 donkey anti-rabbit (IgG) and anti-4 1 5 mouse (IgG) (ThermoFisher Scientific), and 1:10,000 for IRDye 800CW donkey anti-rabbit (IgG) 4 1 6
and anti-mouse (IgG) (LI-COR Biosciences). We used the Odyssey Infrared Imaging System (LI-4 1 7
COR Biosciences) for recording the results. We used black 96-well plates (PerkinElmer) or 13 mm coverslips to grow the cells for IF staining. For collagen coating, we incubated the coverslips or plates O/N at +4 °C with 0.1 mg/ml of collagen For primary antibodies we used the following dilutions: 1:7,500 for anti-SDAg 6 , 1:2,500 for anti-4 4 9
UHV NP-C 53 , 1:2,500 for anti-HISV NP-C 29 , 1:250 for monoclonal anti-HA (ABclonal); and for 4 5 0 secondary antibodies: 1:1,000 for Alexa Fluor 488-or 594-labeled donkey anti-rabbit puncturing the tubes with a thin (23G or 25G) needle. All data generated or analysed in this study are included in this published article (and its 4 7 9 supplementary information files). P  e  r  e  z  -V  a  r  g  a  s  ,  J  .  e  t  a  l  .  E  n  v  e  l  o  p  e  d  v  i  r  u  s  e  s  d  i  s  t  i  n  c  t  f  r  o  m  H  B  V  i  n  d  u  c  e  d  i  s  s  e  m  i  n  a  t  i  o  n  o  f  h  e  p  a  t  i  t  i  s  D  v  i  r  u  s  5  3  1  i  n  v  i  v  o  .  N  a  t  .  C  o  m  m  u  n  .  1  0  ,  2  0  9  8  (  2  0  1  9  )  .  5  3  2  2  8  C  h  a  n  g  ,  W  .  -S  .  e  t  a  l  .  N  o  v  e  l  h  e  p  a  t  i  t  i  s  D  -l  i  k  e  a  g  e  n  t  s  i  n  v  e  r  t  e  b  r  a  t  e  s  a  n  d  i  n  v  e  r  t  e  b  r  a  t  e  s  .  P  r  e  p  r  i  n  t  a  t  :  5  3  3  h  t  t  p  s  :  /  /  w  w  w  .  b  i  o  r  x  i  v  .  o  r  g  /  c  o  n  t  e  n  t  /  1  0  .  1  1  0  1  /  5  3  9  9  2  4  v  1  .  5  3  4  2  9  H  e  p  o  j  o  k  i  ,  J  .  e  t  a  l  .  C  h  a  r  a  c  t  e  r  i  z  a  t  i  o  n  o  f  H  a  a  r  t  m  a  n  I  n  s  t  i  t  u  t  e  s  n  a  k  e  v  i  r  u  s  -1  (  H  I  S  V  -1  )  a  n  d  H  I  S  V  -l  i  k  e  5  3 a  r  t  i  n  e  z  -S  o  b  r  i  d  o  ,  L  .  ,  G  i  a  n  n  a  k  a  s  ,  P  .  ,  C  u  b  i  t  t  ,  B  .  ,  G  a  r  c  i  a  -S  a  s  t  r  e  ,  A  .  &  d  e  l  a  T  o  r  r  e  ,  J  .  C  .  D  i  f  f  e  r  e  n  t  i  a  l  5  8  0  i  n  h  i  b  i  t  i  o  n  o  f  t  y  p  e  I  i  n  t  e  r  f  e  r  o  n  i  n  d  u  c  t  i  o  n  b  y  a  r  e  n  a  v  i  r  u  s  n  u  c  l  e  o  p  r  o  t  e  i  n  s  .  J  .  V  i  r  o  l  .  8  1  ,  1  2  6  9  6  -1  2  7  0  3  5  8  1  (  2  0  0  7  )  .  5  8  2  5  1  P  a  n  e  t  h  I  h  e  o  z  o  r  -E  j  i  o  f  o  r  ,  R  .  e  t  a  l  .  V  a  c  c  i  n  i  a  v  i  r  u  s  -f  r  e  e  r  e  s  c  u  e  o  f  f  l  u  o  r  e  s  c  e  n  t  r  e  p  l  i  c  a  t  i  o  n  -d  e  f  e  c  t  i  v  e  5  8  3  v  e  s  i  c  u  l  a  r  s  t  o  m  a  t  i  t  i  s  v  i  r  u  s  a  n  d  p  s  e  u  d  o  t  y  p  i  n  g  w  i  t  h  P  u  u  m  a  l  a  v  i  r  u  s  g  l  y  c  o  p  r  o  t  e  i  n  s  f  o  r  u  s  e  i  n  5  8 
